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Abstract: We examined the relation between reported regular
strenuous exercise or hard physical labor and the incidence of
coronary heart disease (CHD) death and nonfatal myocardial infarc-
tion among 1,533 hypercholesterolemic men aged 35-59 years who
were in the placebo group of the Lipid Research Clinics Coronary
Primary Prevention Trial. The mean follow-up of the cohort was 7.4
years. The men were free of clinical heart disease at entry; men with
an abnormal resting electrocardiogram or graded exercise test also
were excluded.
Introduction
There is mounting evidence that regular strenuous phys-
ical activity is associated with a reduced risk of coronary
heart disease," but whether this relation applies to hyper-
cholesterolemic men remains unresolved. Hypercholestero-
lemic men might particularly benefit from regular strenuous
activity, if regular activity significantly altered lipoprotein
levels' or mitigated their adverse effects. On the other hand,
hypercholesterolemic men might benefit little or not at all
from regular physical activity, if the cardiac benefits do not
outweigh the risks of strenuous activity6 in this subgroup.
We analyzed data from the Lipid Research Clinics (LRC)
Coronary Primary Prevention Trial (CPPT)7'8 to determine
whether reported regular strenuous physical activity is re-
lated to the risk of coronary heart disease among asympto-
matic hypercholesterolemic men.
Methods
Details regarding the design, implementation, and major
results of the CPPT have been previously reported.7'8 The
CPPT was a double blind, placebo-controlled clinical trial
that tested the efficacy of lowering cholesterol levels with
cholestyramine for the primary prevention of coronary heart
disease (CHD). Twelve Lipid Research Clinics recruited
3,806 men, 35-59 years old, with primary hypercholestero-
lemia who were free of symptomatic CHD at entry. The men
were required to have a plasma total cholesterol of 265 mg/
dl (6.85 mmol/L) or greater (295th percentile) and plasma
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Regular physical activity was not associated with the incidence
of CHD (RR = .94, 95% CI = .68, 1.38) in this study population.
Adjustment by the proportional hazards model for age, low-density
lipoprotein cholesterol, smoking, family history of CHD, and occu-
pation did not alter this finding. This observation suggests that
reported regular physical activity may not be related to the risk of
coronary heart disease among asymptomatic, hypercholesterolemic,
middle-aged men. (Am J Public Health 1988; 78:1428-1431.)
low-density lipoprotein cholesterol of 190 mg/dl (4.91 mmol/
L) or greater at entry. Men with a plasma triglyceride greater
than 300 mg/dl (33.07 mmolIL) or with type III hyperlipidemia
were excluded.
Potential participants also were excluded from the trial
if they had any of the following clinical manifestations of
CHD:
* history of definite or suspect myocardial infarction;
* angina pectoris as determined by the Rose question-
naire;
* angina pectoris during submaximal exercise testing.
* various ECG abnormalities indicative of cardiovascu-
lar disease according to the Minnesota code: left
bundle branch block, second or third degree heart
block; two or more consecutive ventricular premature
beats, left ventricular hypertrophy, R on T type
ventricular premature beats, atrial flutter or fibrilla-
tion; or
* congestive heart failure.
Men with a positive exercise test result-ST segment
depression or elevation of 1 mm or more-in the absence of
other manifestations of CHD were not excluded from the
CPPT.
Only men in good health and free of conditions associ-
ated with secondary hyperlipoproteinemia-diabetes mel-
litus, hypothyroidism, nephrotic syndrome, hepatic disease,
hyperuricemia, and notable obesity-were included in the
CPPT. Men also were excluded if they had moderate or
severe hypertension-DBP > 105 mmHg-or were receiving
anti-hypertensive medication or had life-limiting or comorbid
conditions such as cancer or non-atherosclerotic cardiovas-
cular disease.
Participants were randomized into a treatment group
that received cholestyramine and a control group that re-
ceived a placebo; both groups were prescribed an identical
moderate cholesterol lowering diet and attended Lipid Re-
search Clinics every two months. Intervention by the clinic
staffwas restricted to the prescription ofthe study medication
and the diet. The primary end-point for evaluating the
treatment outcome in the CPPT was definite CHD death and!
or definite non-fatal myocardial infarction.7 All participants
initially entered were followed up to the completion of the
trial; the average length of follow-up was 7.4 years.
We restricted the present analysis to CPPT participants
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in the placebo plus diet group (1,899 men) who underwent
graded exercise tolerance testing at entry (1,897 men).
Because we wanted to minimize the likelihood that sub-
clinical CHD might distort the relation between strenuous
activity and CHD, we excluded participants with other
resting electrocardiographic abnormalities according to the
Minnesota code (24 men), such as minor Q wave or ST
segment changes, a positive graded exercise tolerance test
(266 men), or a history of intermittent claudication (three
men). Because of their small number, 71 men who were not
White were also excluded. Thus, 80 per cent (1,533 men) of
the original CPPT placebo group was included in the analysis.
We determined the level of each participant's habitual
physical activity by the response to two questions asked to
select a target heart rate for the baseline graded exercise
tolerance test. The first question was, "Do you regularly
engage in strenuous exercise or hard physical labor?" Par-
ticipants who answered no to the first question were classified
as inactive. If the answer was yes, the participant was then
asked, "Do you labor or exercise strenuously at least three
times a week?" Since 77 per cent of the participants who
answered yes to the first question reported strenuous exer-
cise or hard physical labor at least three times a week,
participants who responded yes to the first question were
classified as active. Eighty-two per cent of those classified as
inactive based upon the baseline assessment reported that
they did not engage in regular strenuous activity at each
annual follow-up examination in years 2 through 7 of the
CPPT.
We examined the validity of self-reported physical
activity indirectly by demonstrating expected relationships
with other factors-resting heart rate, graded exercise toler-
ance test performance, daily dietary caloric intake, and
subjective rating of activity level outside ofwork-measured
at screening visit 2. In addition, prior analyses from both the
LRC Prevalence Study and the CPPT had demonstrated that
self-reported physical activity based upon the response to the
same two questions was related to plasma levels of high-
density lipoprotein cholesterol.9"10
Factors that might confound the relation between regular
strenuous activity and CHD also were assessed at entry into
the CPPT. These included: total cholesterol, low-density
lipoprotein cholesterol (LDL-C) (pre-diet), high-density lipo-
protein cholesterol (HDL-C) (pre-diet), age, family history of
heart disease, cigarette smoking, systolic blood pressure,
Quetelet index, alcohol consumption, fasting plasma glucose,
education, and occupation.
We examined the incidence of CHD death and/or non-
fatal myocardial infarction (MI) in relation to the self-report
of regular strenuous physical activity at entry into the CPPT.
We also examined the relation between regular strenuous
activity and CHD in a proportional hazards model that
adjusted for baseline differences between physically active
and inactive men in other risk factors at entry into the CPPT.
Results
We indirectly validated our assessment of physical
activity in our analysis sample by demonstrating expected
relationships with other factors, shown in Table 1. As
expected, on the average active males had a lower resting
heart rate and a lower heart rate at the end ofthe second stage
of the graded exercise tolerance test, a longer graded exercise
tolerance test duration, and a higher daily dietary caloric
TABLE 1-Validation of Reported Regular Physical Activity
Active Inactive





Stage 2 Heart Rate
(beats/min) 129 137
Total duration (sec) 615 572
Daily Dietary Intake (cal/kg) 30 29
Activity Outside Work* 2 3
*Based upon a subjective rating on a scale from 1 to 5; 2 = somewhat more than
average, 3 = average.
intake, and rated their activity outside of work as somewhat
more than average, compared to inactive men.
The baseline characteristics of the men included in our
analysis are shown according to their self-reported activity
status in Table 2. As expected, active males had higher levels
of HDL-C, were less likely to smoke, and more likely to
engage in occupations that required manual labor, compared
to inactive males. In addition, active males consumed more
alcohol and were slightly more likely to have a family history
of premature CHD. Total cholesterol, LDL-C, age, systolic
blood pressure, Quetelet index, fasting glucose, and the
proportion of college graduates were similar in the two
groups.
The incidence of coronary heart disease death and/or
nonfatal infarction was similar among active and inactive
males (Table 3). Thus, physical activity was not related to the
risk of CHD as reflected by our estimates of relative risk.
Adjustment by the proportional hazards model for differ-
ences in the baseline characteristics and the length of fol-
low-up did not alter these findings. In addition, our findings
TABLE 2-Baseline Characteristics According to Reported Regular Phys-
ical Activity
Active Inactive
Characteristics (N = 489) (N = 1044)
Means
Total cholesterol (mg/dI)t 292 291
LDL cholesterol* (mg/dl)t 219 218
HDL cholesterol* (mg/dl)t 47 44
Age (years) 47 47
Systolic BP (mm Hg) 123 123
Quetelet index (gr/sq cm) 2.63 2.63
Fasbng plasma glucose (mg/dl)4 98 98
Alcohol consumption (g/day) 10.9 9.5
Percentage
Current smokers 31 39
Family history heart disease 27 24






tConversion factor for mmol/L: 0.02586
*Conversion factor for mmol/L: 0.05551
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TABLE 3-Unadjusted Incidence of Coronary Heart Disease According to
Reported Regular Physical Activity
Relative
Active Inactive Risk
Outcome (N = 489) (N = 1044) (95% Cl)
Cases/1 000
persons/year(N)
Definite CHD death and/or
definite nonfatal
myocardial infarction 11.9 (43)* 12.6 (98)* .94t
(.68, 1.38)
Definite CHD death 1.9 (7) 1.9 (15)
Definite nonfatal
infarction 10.2 (37) 11.1 (85)
Definite or suspect CHD
death and/or nonfatal
myocardial infarction 17 (59)* 16.8 (129)* 1.01
(.75, 1.37)
Definite or suspect
CHD death 2.4 (9) 2.2 (18)
Definite or suspect
nonfatal myocardial
infarction 14.6 (52) 15.0 (115)
*A man experiencing a myocardial infarction and CHD death is counted once in this
category; hence, this line is not the sum of the following two lines.
tAfter adjustment for age, smoking, LDL-cholesterol, family history of CHD, and
occupation through use of a proportional hazards model, the relative risk = .98, 95%
confidence interval = .68, 1.41.
were similar when we considered only men who reported
strenuous activity at least three times a week as active.*
Examination of survival curves for combined fatal CHD
and non-fatal MI according to baseline activity status con-
firmed the lack of an effect of reported activity on the risk of
CHD during the entire follow-up period.* These findings
were similar for fatal CHD and non-fatal myocardial infarc-
tion examined separately.*
Discussion
Our data suggest that reported regular strenuous activity
or hard physical labor is not related to the incidence ofCHD
death and/or non-fatal myocardial infarction in asymptomatic
hypercholesterolemic men. Although this finding may reflect
a lack of effect, there are several alternative explanations that
need to be considered.
First, misclassification of activity status might have
obscured an effect of regular strenuous activity on the risk of
CHD. We used a self-report of regular strenuous exercise or
hard physical labor to characterize the level of habitual
physical activity. The intensity, frequency, and duration of
participation in specific types of physical activity were not
measured. However, 77 per cent of the men in our analysis
sample who reported some strenuous activity indicated that
they regularly engaged in that activity for three or more times
per week. In addition, we indirectly demonstrated the valid-
ity of self-reported activity in our study population. It is
unlikely that the differences observed between active and
inactive men in resting and graded exercise stage 2 heart rate,
treadmill test duration, and HDL-C occurred by chance alone
(P < .001 for each comparison). However, our analysis does
not preclude the possibility of some misclassification, as
suggested by the absence of larger differences between active
*Data available from authors on request.
and inactive men in these measures that indirectly reflect
variability in strenuous physical activity. Nevertheless, we
consider the self-report of regular strenuous activity or hard
physical labor an indication that the man was physically
active and not sedentary at entry into the CPPT.
Second, the statistical power of our analysis to detect an
association between regular activity and CHD was somewhat
limited, as reflected by the width ofthe 95% confidence limits
for our estimates of relative risk. It is possible that we missed
a decrease or increase in risk associated with regular activity
of approximately 30 per cent, but it is unlikely that we missed
the 50 per cent risk reduction demonstrated in previous
epidemiologic studies of heterogeneous populations.'" Fur-
thermore, our best estimate of effect-the point estimate-
suggests a very weak or no association between reported
activity and CHD in our study population.
Third, males who were older, hypertensive, obese, or
diabetic were excluded from the CPPT. Since we have
previously suggested that males who are older, hypertensive,
or obese might particularly benefit from activity," these
selection criteria might have influenced our estimate ofeffect.
Nevertheless, we consider the presence of hypercholestero-
lemia, defined in the CPPT as a total cholesterol - 95th
percentile for middle-aged males, the major difference be-
tween our study population and those of previous studies. '
For these reasons, our results are not directly comparable to
those from other study populations, and it might not be
appropriate to generalize our finding of no effect to persons
with lower levels of plasma cholesterol and/or other CHD
risk factors.
Regular strenuous activity has been suggested as an
adjunct to the treatment of hypercholesterolemia. 2 In part,
this recommendation is based upon the relationship between
activity and HDL-C.5 Active men had a higher plasma level
of HDL-C at entry into the CPPT. The difference in HDL-C
between active and inactive men was greater than that
observed in exercisers versus controls in a one-year random-
ized study of the effects of exercise on plasma lipoproteins'3
and in a recent report from the Multiple Risk Factor Inter-
vention Trial where leisure-time physical activity was in-
versely related to the incidence of first majorCHD events and
overall mortality. 4 Based upon the relation between HDL-C
level and CHD in the CPPT placebo group, we might have
expected active men to have an overall 10 per cent reduction
in CHD.'5 Our analysis did not have adequate statistical
power to detect an effect of this magnitude. However, it is
also possible that the potential benefit of activity is balanced
by the cardiac risks of activity in hypercholesterolemic men.
Our data suggest that reported regular strenuous phys-
ical activity may not be related to the risk of CHD among
asymptomatic hypercholesterolemic middle-aged men. Thus,
regular activity might not mitigate the effect of life-long
hypercholesterolemia. For now, greater attention to other
potential interventions that reduce the risk of CHD among
hypercholesterolemic men' seems appropriate.
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'Hospitals, Health Care Professionals and AIDS' Is Conference
Theme
The American SocietyofLaw& Medicine (ASLM), Public Responsibilityin Medicine and Research
(PRIM&R), and the Harvard AIDS Institute will hold a major national conference on 'Hospitals,
Health Care Professionals and AIDS" at the Boston Park Plaza Hotel, December 1-2, 1988.
The meeting will focus on such charged and troubling issues as: the ethical duty to care for AIDS
patients; discrimination against health care providers and patients; financing care and reimburse-
ment; research and clinical initiatives; the rights of AIDS patients to experimental treatment;
infection control; screening of patients; HIV-infected surgeons.
At the conference, issues will be discussed byleading national speakers from the fields ofclinical
research, medicine, law, support groups for AIDS patients and bioethicists. Conference registrants
will also havean opportunity to participate in topical workshops and plenary sessions during the two-
day meeting.
For further conference and registration information, contact Robyn Carey, Assistant Director,
PRIM&R, 132 Boylston Street, Boston, MA 02116. Tel: (617) 423-4112; or Sharon Paaso, Associate
Director, ASLM, 765 Commonwealth Avenue, Boston, MA 02215. Tel: (617) 262-4990.
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